Associated Papers
Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state.
Rominger MC et al.
Cell Reports, 2025
RIT1 Drives Oncogenic Transformation and Is an Actionable Target in Lung Adenocarcinoma.
Mozzarelli AM et al.
Cancer Research, 2025
Refined variant calling pipeline on RNA-seq data of breast cancer cell lines without matched-normal samples.
Eberth S et al.
Bmc Research Notes, 2025
39955561 (PubMed )
Supplement: 13104_2025_7140_MOESM3_ESM.xlsx › snv_indel_maf_less20_Project_bc
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
Chen S et al.
Cancer Discovery, 2022
Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia.
Cavé H et al.
European Journal of Human Genetics : Ejhg, 2016
Oncogenic RIT1 mutations in lung adenocarcinoma.
Berger AH et al.
Oncogene, 2014
24469055 (PubMed )
Supplement: 41388_2014_BFonc2013581_MOESM15_ESM.pdf
Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies.
Gómez-Seguí I et al.
Leukemia, 2013
[Mutation and amplification of RIT1 gene in hepatocellular carcinoma].
Li JT et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics, 2004
Select a paper to view details